JPMorgan Downgrades Alcoa Stock to Underweight
JPMorgan lowers its rating on Alcoa to Underweight, raises the price target to $50, and explains why aluminum looks less attractive than copper right now.
NOTRELOAD AI
Immuneering's Pancreatic Cancer Data Fails to Impress: Stock Plunges 23% Despite Survival Claims
Immuneering (IMRX) reports 64% survival rate for Atebimetinib in pancreatic cancer trial, but shares plunge 23% as investors remain unconvinced about cross-trial comparisons and competitive threats.
Globus Medical Stock Surges on Strong Q4 Results and Optimistic 2026 Outlook
Globus Medical (GMED) shares jump 9.4% in premarket trading after reporting preliminary Q4 sales of $823.2M, beating analyst estimates, with strong 2026 guidance signaling continued growth momentum.
UBS Upgrades Gap Stock to Buy, Price Target Hits $41
UBS raises Gap stock rating to Buy with $41 price target, citing improved sales outlook, beauty and handbag expansion, and Athleta growth potential.
Trump Calls for $1.5 Trillion Defense Budget Hike, Claims Tariffs Will Cover Costs
President Trump proposes 50% increase in US military spending to $1.5 trillion by 2027, citing tariff revenue as funding source despite budget concerns.
Applied Digital Crushes Q2 Expectations with Strong AI Data Center Growth
Applied Digital (APLD) reports Q2 2026 earnings that exceed analyst estimates, driven by AI data center expansion and major hyperscaler partnerships.